A 62-year-old man with a 40-pack-year smoking history undergoes a routine preoperative chest radiograph prior to an elective inguinal hernia repair. The radiograph reveals a cm solitary, non-calcified peripheral opacity in the right upper lobe. The patient is asymptomatic, with no cough, hemoptysis, or weight loss. Vital signs are within normal limits, and physical examination is unremarkable.
Arrange the following diagnostic imaging and interventional steps in the most appropriate chronological sequence for evaluating this patient's solitary pulmonary nodule. Assume that each step yields findings that raise the suspicion of malignancy, thereby necessitating the subsequent procedure.
- 1Retrospective comparison with previous historical chest imaging
- 2High-resolution computed tomography (HRCT) of the chest without contrast
- 318F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan
- 4Computed tomography (CT)-guided percutaneous transthoracic needle biopsy
Cevap
The correct sequence is: 1) Retrospective comparison with previous imaging, 2) High-resolution CT of the chest, 3) FDG-PET scan, 4) CT-guided percutaneous biopsy.
The evaluation of a solitary pulmonary nodule follows a strict algorithm designed to minimize unnecessary invasive testing. Reviewing old imaging is the most crucial initial step to establish temporal stability. If the nodule is new or growing, HRCT provides essential morphologic detail to estimate malignancy risk. For intermediate-to-high risk solid nodules larger than mm, an FDG-PET scan assesses metabolic avidity and rules out occult metastases. Finally, once functional imaging indicates a high likelihood of malignancy, a tissue biopsy confirms the histopathologic diagnosis to guide definitive therapy.
Adım Adım Çözüm
Anahtar Kavram
The sequential evaluation of a solitary pulmonary nodule prioritizes noninvasive review of historical imaging, followed by anatomic characterization (CT), metabolic assessment (PET), and finally invasive tissue sampling (biopsy).